These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 8630641

  • 1. Safety of meloxicam: a global analysis of clinical trials.
    Distel M, Mueller C, Bluhmki E, Fries J.
    Br J Rheumatol; 1996 Apr; 35 Suppl 1():68-77. PubMed ID: 8630641
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Comparison of the incidence rates of selected gastrointestinal events reported for patients prescribed celecoxib and meloxicam in general practice in England using prescription-event monitoring (PEM) data.
    Layton D, Hughes K, Harris S, Shakir SA.
    Rheumatology (Oxford); 2003 Nov; 42(11):1332-41. PubMed ID: 12810929
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Efficacy and tolerability of meloxicam in an observational, controlled cohort study in patients with rheumatic disease.
    Degner F, Sigmund R, Zeidler H.
    Clin Ther; 2000 Apr; 22(4):400-10. PubMed ID: 10823362
    [Abstract] [Full Text] [Related]

  • 11. Risk of serious upper gastrointestinal and cardiovascular thromboembolic complications with meloxicam.
    Singh G, Lanes S, Triadafilopoulos G.
    Am J Med; 2004 Jul 15; 117(2):100-6. PubMed ID: 15234645
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Meloxicam in osteoarthritis: a 6-month, double-blind comparison with diclofenac sodium.
    Hosie J, Distel M, Bluhmki E.
    Br J Rheumatol; 1996 Apr 15; 35 Suppl 1():39-43. PubMed ID: 8630635
    [Abstract] [Full Text] [Related]

  • 14. Comparison of the incidence rates of selected gastrointestinal events reported for patients prescribed rofecoxib and meloxicam in general practice in England using prescription-event monitoring data.
    Layton D, Heeley E, Hughes K, Shakir SA.
    Rheumatology (Oxford); 2003 May 15; 42(5):622-31. PubMed ID: 12709537
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A double-blind study to compare the efficacy and safety of meloxicam 15 mg with piroxicam 20 mg in patients with osteoarthritis of the hip.
    Lindén B, Distel M, Bluhmki E.
    Br J Rheumatol; 1996 Apr 15; 35 Suppl 1():35-8. PubMed ID: 8630634
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Safety and efficacy of meloxicam in the treatment of osteoarthritis: a 12-week, double-blind, multiple-dose, placebo-controlled trial. The Meloxicam Osteoarthritis Investigators.
    Yocum D, Fleischmann R, Dalgin P, Caldwell J, Hall D, Roszko P.
    Arch Intern Med; 2000 Oct 23; 160(19):2947-54. PubMed ID: 11041902
    [Abstract] [Full Text] [Related]

  • 19. A double-blind, randomized, placebo-controlled study of efficacy and tolerance of meloxicam treatment in patients with osteoarthritis of the knee.
    Lund B, Distel M, Bluhmki E.
    Scand J Rheumatol; 1998 Oct 23; 27(1):32-7. PubMed ID: 9506875
    [Abstract] [Full Text] [Related]

  • 20. A long-term study to evaluate the safety and efficacy of meloxicam therapy in patients with rheumatoid arthritis.
    Huskisson EC, Ghozlan R, Kurthen R, Degner FL, Bluhmki E.
    Br J Rheumatol; 1996 Apr 23; 35 Suppl 1():29-34. PubMed ID: 8630633
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.